-
NAD+ Application in Pharmaceutical Industry and Regulatory Status in Multiple Countries and Markets
Nurah Ekhlaque
April 25, 2025
This article highlights key applications, clinical trial developments, and regulatory classifications of NAD? and its derivatives across major global markets.
-
Chemical Synthesis and Bulk Sourcing of NMN
Noor Saleh
February 26, 2021
Nicotinamide Mononucleotide, abbreviated as NMN or β-NMN, is a nucleotide that is derived from Ribose and Nicotinamide, as illustrated in the following Figure No. 01.
-
Enzymatic Synthesis of NMN: Greener and More Efficient
PharmaSources/Yuntian
February 19, 2021
NMN, i.e., nicotinamide mononucleotide (Fig. 1), is a reaction product of nicotinamide phosphoribosyltransferase (NAMPT).
-
NMN: A Star Drug on the Way toward a “Miracle Drug”
PharmaSources/Yuntian
January 28, 2021
As a new star API, NMN, i.e., nicotinamide mononucleotide, is a reaction product of nicotinamide phosphoribosyltransferase (NAMPT).
-
EZZ moves closer to breakthrough with world-first study into anti-aging product, NMN
prnasia
September 28, 2021
Australian health and wellness company, EZZ Life Science Holdings, is advancing scientific research of popular anti-aging product Nicotinamide mononucleotide (NMN?)...
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
